Achieving significant weight loss is something to be proud of. However, following GLP-1 medications, some patients face a new set of concerns, such as a hollowed face, looser skin, a dull complexion, or increased hair fall, which can be additional stress for an arduous weight loss journey.
With the rise in popularity of GLP-1 medications, our specialist dermatologists at DermAlly see an increase in post-weight loss skin and hair concerns, and recognise them as a distinct clinical area.
At DermAlly, we understand how frustrating it is for patients to work hard to improve their health, only to face an entirely new set of physical changes. Our dermatologists are here to help them navigate these concerns.
Reviewed By:
TLDR Summary:
The concerns may look cosmetic, but most of them are medically driven, especially if it is through medical weight loss such as GLP-1s. That distinction matters significantly, as it determines whether the treatment post-GLP-1 patients receive addresses the concerns at their root, and for the long term.
Telogen effluvium, iron deficiency alopecia, androgenetic alopecia unmasked by weight loss, and thyroid-related hair loss can all look identical from the outside. An aesthetic clinic offering scalp treatments has no tools to distinguish between them.
A dermatologist runs blood panels and performs a scalp examination first. If ferritin levels are at 8, no amount of scalp treatment will resolve the shedding. Getting the blood work done and correcting the deficiency is what stops the fall. The diagnosis must come before the treatment, or the treatment is a guess.
Skin during rapid weight loss is often protein-depleted, dehydrated from suppressed thirst signals, and has an impaired lipid barrier from reduced dietary fat intake. Energy-based treatments that stimulate collagen production rely on the skin’s wound-healing response to deliver results. If protein stores are insufficient, that healing response is compromised and results will be suboptimal at best.
An aesthetic clinic assesses what it can see. A dermatologist assesses the systemic context: rate of weight loss, nutritional status, barrier integrity, and whether the post-GLP-1 patient’s skin is in a state to respond to treatment at all. Doing the right treatment on the wrong skin produces the wrong outcome.
The right sequence for many post-GLP-1 patients is nutritional stabilisation first, barrier support second, and energy-based or injectable treatments third. A clinic that earns from selling devices and injectables has no commercial reason to recommend that post-GLP-1 patients come back in three months once protein intake is adequate. A dermatologist’s job is the outcome, not the visit. That difference in incentive is what determines whether post-GLP-1 patients are told what they need to hear.
If the acne is driven by androgen changes from a rapid body composition shift, prescription medication is the only thing that addresses it at the root. An aesthetic clinic cannot prescribe. Treating hormonally driven acne with facials or peels while the androgen cause remains active keeps post-GLP-1 patients in a cycle. Performing aggressive treatments on acne-active, nutritionally stressed skin also carries a real risk of post-inflammatory hyperpigmentation. Getting the right diagnosis first determines whether treatment helps or causes additional damage.
Radiofrequency microneedling and focused ultrasound treatments work by creating controlled thermal injury that the body then repairs by producing new collagen. That repair process requires protein. If GLP-1 patients are still in a period of active, rapid weight loss and protein and micronutrient reserves are depleted, their skin lacks the building blocks to mount an adequate healing response. The result is suboptimal collagen production and, in some cases, an inflamed barrier that takes longer to recover than it should. A dermatologist assesses whether post-GLP-1 patients’ skin is in a biological state to respond to treatment before recommending it, not after.
Concern | How It Shows |
|---|---|
Facial volume loss | Hollowed cheeks, sunken eyes, prominent bone structure |
Skin laxity and sagging | Loose skin at the jaw, neck, and body; crepey texture |
Skin dullness and dryness | Flat, rough, dry complexion; loss of skin brightness |
Hair shedding | Increased daily hair loss; scalp becoming visible |
Hormonal acne flares | New or worsening breakouts during weight loss |
GLP-1 medications can produce rapid, significant weight loss. The face is often the first place patients notice the impact.
Facial fat is distributed across distinct compartments: the cheeks, temples, the area around the eyes, and the lower face. When these reduce in volume faster than the overlying skin can adapt, the face takes on a hollowed, deflated appearance.
The deep fat pads beneath the skin provide structural volume and support. Rapid weight loss reduces these fat compartments faster than the skin above can contract. Research also shows that significant weight loss alters dermal collagen architecture, reducing the thickness and organisation of collagen fibres, which makes the skin appear thinner and less supported. Both effects occur simultaneously, which is why the change in the face can feel sudden and significant.
Following a thorough assessment, our dermatologists will discuss a personalised treatment plan with post-GLP-1 patients. Depending on the degree of volume loss and skin quality, options may include:
Treatment | What It Does | Suitable For |
|---|---|---|
Collagen-stimulating injectable treatment | Delivered into the deep tissue planes of the face to rebuild structural support by stimulating the body’s own collagen production over time | Mid-face and temple volume loss; gradual, natural-looking improvement |
Hyaluronic acid-based injectable | Restores volume to specific areas such as the cheeks, temples, and perioral region, with more immediate structural support | Targeted deflation where faster volume restoration is appropriate |
Combination approach | Collagen-stimulating and hyaluronic acid treatments may be used together depending on the distribution and severity of volume loss. | Patients with more widespread facial deflation |
A note on treatment selection for weight-loss-related volume loss: For many patients, collagen-stimulating injectables are considered before hyaluronic acid-based fillers as a first approach. Unlike hyaluronic acid injectables that restore volume directly, collagen-stimulating treatments work by triggering the body’s own fibroblasts to produce new collagen and elastin over several months, rebuilding the structural scaffolding that weight loss has depleted. This distinction matters for post-GLP-1 patients specifically, because the underlying deficit is architectural, not just volumetric. Our dermatologists will advise on which approach, or which sequence, is most appropriate for the degree of volume loss and skin quality.
When the structural support beneath the skin (both fat and collagen) is reduced, the skin may no longer conform closely to the face and body. This is one of the most common and persistent concerns following significant weight loss.
Skin laxity does not reliably improve on its own, even if some weight is regained, because collagen structural changes are not reversed simply by fat returning.
The skin’s firmness depends on collagen and elastin, structural proteins that provide strength and elasticity. Both require a sufficient supply of protein and micronutrients. During periods of significant caloric restriction on GLP-1 medications, protein and nutrient intake can fall short of what is required for adequate collagen synthesis. At the same time, the mechanical support of subcutaneous fat is removed. Skin that has carried more volume for longer, or in older patients, has less residual elasticity to contract around a smaller frame.
Treatment | What It Does | Suitable For |
|---|---|---|
Radiofrequency microneedling | Delivers controlled radiofrequency energy at multiple depths through fine needles, stimulating collagen remodelling and new collagen production in the dermis. Improvement develops progressively over weeks to months. | Facial and neck laxity, skin texture, and firmness can be used on body areas |
Focused ultrasound treatment | Uses acoustic energy to create precise heating in the deeper structural layers of the skin, triggering a lifting and tightening response. Results develop over two to three months. | Lower face, jawline, and neck laxity; skin lifting without surgery |
A combination of both | The two modalities address different tissue depths and can be used sequentially or together, where the degree of laxity warrants it. | More marked skin laxity at multiple tissue depths |
Many patients on GLP-1 medications notice that their skin looks different well before they notice any structural change. The complexion loses its brightness. The skin feels dry and rough. These changes have a clear biological basis and are often manageable.
GLP-1 medications reduce appetite, but they also reduce thirst signals for many patients. Systemic dehydration is a common and underappreciated consequence, with direct effects on skin quality. Caloric restriction also reduces dietary fat intake, which can impair the skin’s lipid barrier. Collagen production slows when protein and micronutrient delivery fall short. Together, these factors produce the dull, dry, and rough presentation that many patients describe.
Treatment | What It Does | Suitable For |
|---|---|---|
Skin booster treatment | Injectable treatment that deposits hydrating agents directly into the dermis, improving the skin’s capacity to retain moisture and restoring surface brightness and texture from within | Persistent dullness, dryness, and loss of skin luminosity |
Skincare guidance | Our dermatologists will advise on barrier-supporting skincare habits, including appropriate moisturisers, active ingredients to support collagen, and sun protection. | All patients, as a foundation alongside any in-clinic treatment |
Increased hair shedding is one of the most frequently reported concerns following significant GLP-1 weight loss, and one of the most alarming to experience. The good news is that in most cases, this is a temporary and reversible condition.
Hair follicles operate on a growth cycle. When the body experiences significant physiological stress, including rapid weight loss, a larger-than-usual proportion of follicles shift simultaneously from the active growth phase (anagen) into the resting phase (telogen). Two to four months later, these resting hairs shed at once. This is known as telogen effluvium.
Telogen effluvium is not a permanent condition. The follicles remain intact and viable. Once the triggering stress resolves, weight stabilises, and nutrition improves, the growth cycle recovers, and new hair begins to grow.
Several factors can worsen or prolong hair shedding: inadequate protein intake (hair is made of keratin, a structural protein), low iron and ferritin stores, deficiencies in zinc, selenium, or vitamin D, and ongoing caloric restriction. Identifying and correcting these is an important part of management.
It is also worth noting that telogen effluvium can unmask underlying pattern hair loss (androgenetic alopecia) in susceptible individuals. In these patients, the temporary shedding improves, but some thinning may persist because a pre-existing condition was already present before weight loss began. A proper clinical assessment can identify whether this is the case.
Treatment | What It Does | Suitable For |
|---|---|---|
Blood test assessment | Measures iron, ferritin, zinc, selenium, vitamin D, and thyroid function to identify nutritional deficiencies contributing to shedding | All patients presenting with post-weight loss hair shedding; done before any other treatment |
Nutritional correction | Supplementation and dietary adjustment to address identified deficiencies; protein intake optimisation to support follicular recovery | Patients with documented nutritional deficiencies |
Topical treatments | Prescribed topical therapies to support the hair growth cycle during recovery | Patients with persistent or slow-resolving telogen effluvium |
Radiofrequency-based scalp treatment | Delivers controlled radiofrequency energy into the scalp to improve local circulation and support the follicle environment, aiding recovery of the hair growth cycle | Patients with ongoing shedding or slow regrowth after nutritional correction |
Some patients notice new or worsening acne during or after GLP-1 treatment. Hormonal shifts during significant weight loss, changes in metabolism, and fluctuations in dietary intake can all influence sebaceous gland activity and create conditions that promote inflammatory hormonal acne.
Rapid changes in body composition alter hormonal balance, including levels of androgens that drive sebum production. Changes to diet can also affect gut microbiome activity and skin inflammation. These shifts create a window during which acne can appear or flare, particularly in patients already prone to hormonal breakouts.
Acne management during or after GLP-1 treatment follows the same clinical approach as acne management generally, but is tailored to account for the additional skin stress of the weight loss period. Our dermatologists will assess the type, pattern, and severity of breakouts before recommending a treatment plan. Where hormonal influences are suspected, further assessment may be appropriate.
For more information, visit our Hormonal Acne page.
In-clinic treatments may see better success when paired with nutritional support:
What to Address | Why It Matters |
|---|---|
Protein intake | Hair is made of keratin, a structural protein. Collagen production also requires protein. Inadequate protein intake is one of the most consistent drivers of both hair shedding and skin quality decline during caloric restriction. |
Iron and ferritin | Low iron and ferritin are among the most common causes of diffuse hair shedding, especially in women. A blood test confirms whether levels are low. |
Zinc, selenium, and vitamin D | All play roles in follicular function and skin repair. Deficiencies worsen hair and skin changes and are commonly depleted in patients on restricted diets. |
Hydration | GLP-1 medications reduce thirst signals as well as appetite. Small, regular sips throughout the day, including electrolyte-supplemented fluids where appropriate, help maintain skin hydration from within. |
Pacing of weight loss | Extremely rapid weight loss places greater physiological stress on the skin and hair. Discussing rate of weight loss with the prescribing doctor can meaningfully reduce the severity of skin and hair changes. |
At DermAlly, post-weight loss skin and hair concerns are assessed by our MOH-accredited specialist dermatologists as a full clinical picture, not a checklist of treatments to be applied. Rehabilitating skin and hair after significant weight loss requires a phased, medically led approach.
Before any treatment is recommended, we assess the internal environment of post-GLP-1 patients.
Any deficiencies in iron, ferritin, or protein?
Skin barrier compromised and reactive?
We establish what the nutritional status is, whether their skin is in a state to respond to treatment, and what is actually driving the changes they are experiencing. Where blood tests are needed, we recommend them at this stage. No treatment plan is personalised until the biology is understood.
For hair shedding, once nutritional deficiencies are identified and addressed, we introduce evidence-based interventions to support the hair growth cycle. This may include prescribed topical therapies and, where appropriate, in-clinic scalp treatments. We monitor closely to ensure the shedding phase has resolved before any more stimulatory treatments begin.
For skin laxity and volume loss, we prioritise rebuilding the structural scaffolding before refining the surface. Collagen-stimulating injectable treatments are often recommended before energy-based devices, because the foundation needs to be strengthened before surface treatments can deliver their best results. Once the structural work is underway, energy-based treatments can be introduced to refine texture and firmness.
Our assessment will cover post-GLP-1 patients’ weight loss timeline, nutritional status, skin and hair history, any contributing hormonal or medical factors, and personal goals. Our dermatologists will discuss a personalised treatment plan based on what that assessment shows.
Most are not. Facial volume loss and skin laxity are structural changes that do not self-correct on their own, but they can be addressed with appropriate treatment. Hair shedding (telogen effluvium) is a temporary condition in the majority of patients; the follicles remain intact, and new hair grows as the body recovers. In some patients with underlying pattern hair loss, a degree of thinning may persist because a pre-existing condition was unmasked rather than caused by weight loss. A clinical assessment helps clarify which situation applies.
The peak shedding period typically occurs two to four months after the most rapid phase of weight loss and gradually slows over the following months. For most patients, significant improvement is seen within six to twelve months. Recovery is faster when nutritional deficiencies, particularly protein, iron, and ferritin, are identified and corrected early. Ongoing caloric restriction or repeated weight fluctuations can prolong the shedding phase.
Yes. Non-surgical approaches, including radiofrequency microneedling and focused ultrasound treatment, stimulate collagen remodelling and improve skin firmness over time. These are established treatment categories for facial and body skin laxity. The degree of improvement depends on the severity of laxity, the quality of the skin, and how long the skin has been stretched. Not every case of skin laxity warrants treatment, and our dermatologists will advise honestly on what is realistic for individual situations.
No. GLP-1 patients do not need to have stopped or completed their weight loss journey before seeking assessment at DermAlly. Many patients benefit from early assessment, particularly for nutritional guidance and hair shedding, while still actively losing weight. For structural concerns like facial volume loss and skin laxity, treatment timing is best discussed with our dermatologists in the context of their overall weight loss plan.
Telogen effluvium is a diffuse, temporary increase in daily hair shedding triggered by a systemic stress such as rapid weight loss. It affects the whole scalp evenly, peaks, and then gradually resolves, and is followed by regrowth. Pattern hair loss (androgenetic alopecia) is a progressive, genetically influenced condition that creates a characteristic thinning pattern, typically at the temples and crown in men, and across the top of the scalp in women. Telogen effluvium can unmask an underlying pattern of hair loss that was already developing before weight loss began. A dermatologist can examine the shedding pattern and scalp to determine which condition is present.
The most clinically relevant tests include full blood count (to assess for anaemia), serum ferritin (iron stores), serum iron, transferrin saturation, zinc, selenium, vitamin D, vitamin B12, folate, and thyroid function tests. Not all patients need every test, and our dermatologists will advise on which panel is most relevant based on the post-GLP-1 patients’ history and presentation. Correcting documented deficiencies is an important first step before other treatments are considered.
Facial ageing from weight loss occurs because of two overlapping effects. First, the deep fat compartments that give the face its youthful volume and support reduce in size, making the face appear deflated or hollow. Second, the collagen network in the dermis changes after significant weight loss, with research showing a reduction in thick collagen fibres and increased elastin density that contributes to skin thinning and laxity. Both effects can make the face appear older than before weight loss, even when overall health has improved significantly. Addressing facial volume loss and skin quality with appropriate dermatological treatment can help restore a more rested and proportionate appearance.
Generally, yes. The faster the weight is lost, the less time the skin has to adapt to the reduced structural support. Rapid weight loss is more strongly associated with significant facial deflation, pronounced skin laxity, and telogen effluvium. Nutritional deficiencies also tend to be more marked when appetite is most severely suppressed. This is one of the reasons pacing weight loss, when medically appropriate, is worth discussing with the GLP-1 prescribing doctor.
Skincare can meaningfully support skin health during the weight loss period, but it has limits. Consistent moisturisation helps maintain barrier function and reduces the compounding impact of external dryness on already depleted skin. Sunscreen limits additional UV-driven collagen breakdown. Certain topical actives, such as low-concentration retinoids and vitamin C serums, can support skin turnover and collagen. However, skincare alone does not address the dermal structural changes or hydration deficit that drive the dullness and dryness seen in many post-weight-loss patients. Our dermatologists can advise on which topicals are appropriate for their skin’s current state, alongside any in-clinic management.
DermAlly’s treating doctors are MOH-accredited specialist dermatologists, not GP-trained aesthetic practitioners. This means the assessment of post-GLP-1 patients’ skin and hair is carried out by doctors with specialist training in the biology of the skin and hair follicle, who can distinguish between conditions that look similar but require different management, and who have access to both medical and aesthetic treatment options. For post-weight loss patients, this matters: hair shedding needs to be properly assessed for nutritional and medical causes before any treatment is recommended, and skin laxity should be evaluated in the context of their overall skin health, not simply treated as a cosmetic concern.
Book an appointment with our expert dermatologists. Please select your preferred clinic below.
